This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: The Innovations of Hans Bigalke
Introduction
Hans Bigalke is a notable inventor based in Germany. He has made significant contributions to the field of biotechnology, particularly in the study of neurotoxins. His work focuses on the development of innovative solutions that have the potential to impact various medical applications.
Latest Patents
Hans Bigalke holds a patent for "Botulinum Neurotoxin A Protein Receptor And Uses Thereof." This invention relates to a polypeptide comprising an amino acid sequence, at least 70 percent of which is identical to the amino acid sequence of the synaptic vesicle glycoprotein of Homo sapiens. The polypeptide binds the HC fragment of botulinum neurotoxin A, provided that the polypeptide is not the synaptic vesicle glycoprotein 2C of Homo sapiens. Despite having no patents listed under his name, his research continues to be influential in the field.
Career Highlights
Hans Bigalke is currently employed at Toxogen GmbH, where he collaborates with other experts in the field. His work at Toxogen GmbH has allowed him to explore the applications of his research in various therapeutic areas.
Collaborations
Some of his notable coworkers include Andreas Rummel and Thomas Binz. Their combined expertise contributes to the innovative environment at Toxogen GmbH.
Conclusion
Hans Bigalke's contributions to biotechnology, particularly in the area of neurotoxins, highlight his role as an influential inventor. His ongoing research and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile